Fischer Medical Ventures Limited

FISCHER

INE771F01025

Specialty Chemicals

Market Closed - Bombay S.E. Other stock markets 06:00:56 2024-06-07 am EDT			5-day change	1st Jan Change
621.9 ^INR	+4.57%		+9.51%	+171.34%

May. 04	Fischer Chemic Limited Announces Board and Executive Changes	CI
Apr. 16	Time Medical International Ventures Pte. Ltd., Shankar Varadharajan and Ravindran Govindan completed the acquisition of 0.0000094% stake in Fischer Chemic Limited for INR 0.00006 million.	CI

Fischer Chemic Limited Approves Executive Changes

June 12, 2019 at 05:20 am EDT

Fischer Chemic Limited at its board meeting held on June 12, 2019 accepted the resignation of Mr. Abhishek Halan, Company Secretary & Compliance officer of Company effective June 11, 2019 and has decided to appoint Mr. Vedant Bhatt as Company Secretary & Compliance officer of the company.

Latest news about Fischer Medical Ventures Limited

Fischer Chemic Limited Announces Board and Executive Changes	May. 04	CI
Time Medical International Ventures Pte. Ltd., Shankar Varadharajan and Ravindran Govindan completed the acquisition of 0.0000094% stake in Fischer Chemic Limited for INR 0.00006 million.	Apr. 15	CI
Fischer Medical to Co-Develop MRI Machine Parts with Spectrum Electrical Industries	Apr. 09	MT
Fischer Chemic Limited has Changed its Name to Fischer Medical Ventures Limited	Mar. 29	CI
Fischer Chemic Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 12	CI
Fischer Chemic Limited announced that it has received INR 775.880768 million in funding from Time Medical International Ventures Pte. Ltd., Blue Lotus Capital Advisors LLP, India Emerging Giants Fund Limited, Vikasa India Eif I Fund, Unistone Capital Private Limited	Jan. 24	CI
Fisher Chemic Limited Approves Shifting of Registered Office	Jan. 13	CI
Time Medical International Ventures Pte. Ltd., Shankar Varadharajan and Ravindran Govindan made an offer to acquire 26% stake in Fischer Chemic Limited for approximately INR 170 million.	Dec. 15	CI
Fischer Chemic Limited Approves the Appointment of Deepak Vyas as Company Secretary & Compliance Officer	Dec. 15	CI
Fischer Chemic Limited Approves Shifting of Registered Office of the Company from the State of Maharashtra to the State of Andhra Pradesh	Dec. 15	CI
Fischer Chemic Limited (BSE : 524743) agreed to acquire Time Medical International Ventures Private Limited for INR 400.8 million	Dec. 14	CI
Fischer Chemic Limited announced that it expects to receive funding from Time Medical International Ventures Pte. Ltd.	Dec. 14	CI
Fischer Chemic Limited Announces Resignation of Aditya Singh, Company Secretary & Compliance Officer Effective December 12, 2023	Dec. 13	CI
Fischer Chemic Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 01	CI
Fischer Chemic Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-12	CI
Fischer Chemic Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-29	CI
Fischer Chemic Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-29	CI
Fischer Chemic Limited announced that it expects to receive INR 23.28 million in funding	23-03-29	CI
Fischer Chemic Board to Consider Issuing Securities to Raise Funds; Shares Slide 5%	23-03-28	MT
Fischer Chemic Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
Fischer Chemic Limited Approves CFO Changes	23-02-03	CI
Fischer Chemic Limited Announces Management Changes	23-02-03	CI
Fischer Chemic Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-17	CI
Fischer Chemic Limited Announces Resignation of Vedant Bhatt as Company Secretary / Compliance Officer	22-10-17	CI
Fischer Chemic Limited Appoints Mr. Sanjay Jayantilal Jain as Independent Director	22-10-01	CI

Chart Fischer Medical Ventures Limited

Duration

Period

More charts

Company Profile

Fischer Medical Ventures Limited, formerly Fischer Chemic Limited, is an India-based company. The Company is primarily engaged in the trading of laboratory chemicals and machineries.

Sector

Specialty Chemicals

Calendar

2024-08-07 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Specialty Chemicals

	1st Jan change	Capi.
FISCHER MEDICAL VENTURES LIMITED	+171.34%	398M
ECOLAB INC.	+20.59%	68.31B
SIKA AG	-1.02%	48.49B
GIVAUDAN SA	+23.82%	44.42B
FUJIFILM HOLDINGS CORPORATION	+30.26%	28.29B
EMS-CHEMIE HOLDING AG	+7.56%	19.12B
SYMRISE AG	+10.55%	16.64B
CELANESE CORPORATION	-5.73%	16B
POSCO FUTURE M CO., LTD.	-21.45%	15.84B
ALBEMARLE CORPORATION	-20.45%	13.51B